Boston Scientific launches U.S. Parkinson's trial, cites interim EU data

June 18, 2013 by Brad Perriello

Boston Scientific launches a U.S. clinical trial of its Vercise deep-brain stimulation treatment for Parkinson's disease and touts interim data from a European trial of the device.

Boston Scientific launches U.S. Parkinson's trial, cites interim EU data

Boston Scientific (NYSE:BSX) said it launched a U.S. clinical trial of its Vercise deep-brain stimulation treatment for patients with Parkinson's disease and touted interim results from a European study of the device.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp